[KROS] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
05-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- 1.66%
YoY- -45.23%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 0 20,000 0 100 0 0 2,500 -
PBT -24,186 -4,942 -20,335 -15,622 -15,835 -10,676 -12,036 59.30%
Tax 1 1,998 -38 -79 50 82 -156 -
NP -24,187 -6,940 -20,297 -15,622 -15,885 -10,676 -12,036 59.31%
Tax Rate - - - - - - - -
Total Cost 24,187 26,940 20,297 15,722 15,885 10,676 14,536 40.46%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 0.00 -34.70 0.00 -15,622.00 0.00 0.00 -481.44 -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -1.01 -0.30 -0.87 -0.67 -0.68 -0.49 -0.60 41.55%
EPS Diluted -1.01 -0.30 -0.87 -0.67 -0.68 -0.49 -0.60 41.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.